Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
11,912,678
-
Share change
-
-2,391,339
-
Total reported value
-
$10,125,354
-
Price per share
-
$0.85
-
Number of holders
-
27
-
Value change
-
-$4,196,491
-
Number of buys
-
6
-
Number of sells
-
13
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q4 2024
As of 31 Dec 2024,
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,912,678 shares.
The largest 10 holders included
HHLR ADVISORS, LTD., MORGAN STANLEY, SG Americas Securities, LLC, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, EDBI Pte Ltd, abrdn plc, CANTOR FITZGERALD, L. P., BNP PARIBAS FINANCIAL MARKETS, and UBS Group AG.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.